Topics

GSK's Trelegy On Track To Be First Triple Inhaled Regimen For Asthma

11:13 EDT 2 Oct 2019 | SCRIP

The company filed an sNDA with the US FDA for the triple combination, hoping to expand its current COPD indication...

      

Related Stories

 

Original Article: GSK's Trelegy On Track To Be First Triple Inhaled Regimen For Asthma

NEXT ARTICLE

More From BioPortfolio on "GSK's Trelegy On Track To Be First Triple Inhaled Regimen For Asthma"

Quick Search

Relevant Topic

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...